Of the pharmaceutical preparations at present in use for the pharmacological control of fertility, those designed according to Pincus' prototype have been the objects of by far the widest experience and are unsurpassed for contraceptive reliability and regularity of cycles. Their mechanism of action will, therefore, constitute the primary topic of this discussion. The conclusions reached will mutatis mutandis be applied to other forms of oral contraception. The so-called Pincus-pill, as is well-known, consists of an estrogenic and a progestational substance and is given for 20 to 22 days during each (artificial) menstrual cycle. Several dozen brands of the combination-pill are now available. They differ mainly in the nature and quantity of the progestational compound, not so much in their estrogen-content, since only two estrogenic substances are used, viz. ethynyl estradiol and mestranol (Fig. I), the 17a-Athinylostradiol 17a-~thinylSstradiol-3-methylither EE (ethinyl estradiol) EE3ME (ethinyl estradiol-3-methylether) Mestranol --c.cn HO --CiCH CHJO / Acta obst. et gynec. scandinav. Vol. XLVIII, suppl. 1, 1969.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.